https://pharmadog.xyz/news/455119 pharmadog en 2026-09-25T19:46:36.000Z FDA approves Mirum's Atebrioz for ultra-rare disease that hardens muscle and connective tissue https://pharmadog.xyz/news/454827 pharmadog en 2026-09-25T17:50:04.000Z UN-backed agency secures sub-licensing deals for generic Roche flu drug across 129 low- and middle-income countries https://pharmadog.xyz/news/454695 pharmadog en 2026-09-25T17:05:24.000Z Jury awards Nektar $90 million in lawsuit against Eli Lilly over licensing dispute https://pharmadog.xyz/news/454527 pharmadog en 2026-09-25T16:51:20.000Z Pharma groups urge FDA to clarify criteria for approving drugs based on a single pivotal trial https://pharmadog.xyz/news/454591 pharmadog en 2026-09-25T16:08:00.000Z Novo’s stock tumbles after two-year GLP-1 boom as AI drug-discovery startups land huge funding rounds https://pharmadog.xyz/news/454359 pharmadog en 2026-09-25T15:41:48.000Z Experts say expanding beyond rare disease markets can make ultra-rare therapies financially viable https://pharmadog.xyz/news/454403 pharmadog en 2026-09-25T15:25:10.000Z FDA approves Lilly's once-weekly basal insulin Onswik for adults with type 2 diabetes https://pharmadog.xyz/news/454215 pharmadog en 2026-09-25T14:49:45.000Z Biomanufacturers Redesign Processes to Blend Emergency Vaccine Readiness with Commercial Flexibility https://pharmadog.xyz/news/454191 pharmadog en 2026-09-25T14:34:34.000Z Legend's five-year data suggests Carvykti could be a cure; Addex, Indivior split https://pharmadog.xyz/news/454216 pharmadog en 2026-09-25T14:04:34.000Z Jury awards Nektar $90 million in damages after lawsuit over broken rezpeg partnership with Eli Lilly https://pharmadog.xyz/news/454192 pharmadog en 2026-09-25T14:00:59.000Z Kali Therapeutics pivots from Chinese drug acquisitions to focus on its own growing pipeline https://pharmadog.xyz/news/454193 pharmadog en 2026-09-25T14:00:58.000Z Azalea Therapeutics wins Endpoints 11 award, combines gene editing with CAR-T and raises $82 million https://pharmadog.xyz/news/454194 pharmadog en 2026-09-25T14:00:55.000Z NewLimit raises $682M to pursue new class of anti-aging drugs https://pharmadog.xyz/news/454195 pharmadog en 2026-09-25T14:00:54.000Z Anew Labs, ByteDance’s biotech spinout, raises $290M to build a China AI bio rival https://pharmadog.xyz/news/454196 pharmadog en 2026-09-25T14:00:53.000Z Stipple Bio wins Endpoints 2026 award for precision pancreatic cancer therapy https://pharmadog.xyz/news/454197 pharmadog en 2026-09-25T14:00:51.000Z Medra, 2026 Endpoints 11 winner, aims to build self-driving labs https://pharmadog.xyz/news/454198 pharmadog en 2026-09-25T14:00:42.000Z SonoThera secures $186 million to advance non-viral gene-therapy platform https://pharmadog.xyz/news/454199 pharmadog en 2026-09-25T14:00:38.000Z Medici wins Endpoints 2026 award, touts personalized cancer therapy https://pharmadog.xyz/news/454200 pharmadog en 2026-09-25T14:00:31.000Z Corsera wins Endpoints 11 2026 award, marking a major bet by veteran biotech leaders Meanwell and Maraganore https://pharmadog.xyz/news/454201 pharmadog en 2026-09-25T14:00:30.000Z Endpoints 11 showcases top biotech startups, signaling renewed optimism and funding https://pharmadog.xyz/news/454202 pharmadog en 2026-09-25T14:00:22.000Z K2 Therapeutics seeks to blend China’s speed with global expertise after winning Endpoints 2026 award https://pharmadog.xyz/news/454203 pharmadog en 2026-09-25T14:00:06.000Z Vivodyne’s Human Tissue Factory Wins Endpoints 11 2026, Promising Faster Drug Testing https://pharmadog.xyz/news/454067 pharmadog en 2026-09-25T13:38:18.000Z Rakuten Medical appoints Hassan Danesi as chief medical officer, coming from Coherus Biosciences https://pharmadog.xyz/news/454047 pharmadog en 2026-09-25T13:34:11.000Z ADARx raises $446 million in one of 2026's largest biotech IPOs as City Therapeutics plans its own listing https://pharmadog.xyz/news/454048 pharmadog en 2026-09-25T13:25:46.000Z Carvykti shows 5-year survival in half of multiple myeloma patients in Phase 2 study https://pharmadog.xyz/news/454087 pharmadog en 2026-09-25T13:21:00.000Z Novo signs €1.2 bn deal with Nanexa for long-acting injectables as Acadia’s Alzheimer trial misses target https://pharmadog.xyz/news/453791 pharmadog en 2026-09-25T12:53:55.000Z Federal judge overturns key disability protection law https://pharmadog.xyz/news/453747 pharmadog en 2026-09-25T12:37:47.000Z Merck's Welireg receives FDA nod for expanded use with Lenvima in kidney cancer https://pharmadog.xyz/news/453771 pharmadog en 2026-09-25T12:27:03.000Z Genentech signs $55M upfront deal with AI firm Earendil Labs to develop bispecific cancer antibodies, potential total value over $1.5B https://pharmadog.xyz/news/453580 pharmadog en 2026-09-25T11:00:47.000Z Travere names former Amicus CEO Bradley Campbell as new leader; Roche eyes board seat for ex‑Takeda chief Alex Hoffman https://pharmadog.xyz/news/454334 pharmadog en 2026-09-25T10:43:00.000Z Lundbeck plans US headquarters move to Boston to boost neuroscience R&D https://pharmadog.xyz/news/453411 pharmadog en 2026-09-25T10:29:34.000Z Novo signs development deal with Swedish biotech Nanexa to license long-acting delivery technology https://pharmadog.xyz/news/453119 pharmadog en 2026-09-25T08:30:00.000Z Tobacco companies submitted 175,000 largely duplicate comments to block FDA menthol cigarette ban https://pharmadog.xyz/news/453121 pharmadog en 2026-09-25T08:30:00.000Z Veteran Russell Shilling leads new federal autism research initiative https://pharmadog.xyz/news/453123 pharmadog en 2026-09-25T08:30:00.000Z Experts say measles death counts are muddled by 'with' vs 'of' debate https://pharmadog.xyz/news/453122 pharmadog en 2026-09-25T08:30:00.000Z Opinion: RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count https://pharmadog.xyz/news/453120 pharmadog en 2026-09-25T08:30:00.000Z Five candidates vie for WHO director‑general role as agency faces US funding pullback and tighter global health budgets https://pharmadog.xyz/news/452907 pharmadog en 2026-09-25T07:46:39.000Z ADARx prices $446.3 million Nasdaq debut, boosting biotech IPO wave https://pharmadog.xyz/news/453218 pharmadog en 2026-09-25T05:24:00.000Z Indivior ends Addex PAM collaboration as it prepares for Supernus merger https://pharmadog.xyz/news/453219 pharmadog en 2026-09-25T04:54:00.000Z Novo signs $1.3 billion deal with Nanexa to add long-acting injectables for obesity and diabetes https://pharmadog.xyz/news/455222 pharmadog en 2026-09-25T04:00:00.000Z Boston Scientific recalls Imager II angiographic catheters over tip detachment risk https://pharmadog.xyz/news/452774 pharmadog en 2026-09-25T02:52:00.000Z Genentech signs $1.5 billion bispecific antibody deal with Earendil Labs https://pharmadog.xyz/news/452775 pharmadog en 2026-09-25T02:47:00.000Z ADARx upsizes Nasdaq IPO to $446M as City Therapeutics eyes public listing https://pharmadog.xyz/news/451579 pharmadog en 2026-09-25T00:36:00.000Z RNAi biotech ADARx raises $446 million in IPO, secures $89 million from AbbVie https://pharmadog.xyz/news/453722 pharmadog en 2026-09-24T21:20:00.000Z China NewCo model pioneer sued in US over alleged trade secret theft and double-dealing https://pharmadog.xyz/news/450967 pharmadog en 2026-09-24T21:08:00.000Z FDA advisory panel finds Grail's Galleri multicancer blood test benefits outweigh risks https://pharmadog.xyz/news/451026 pharmadog en 2026-09-24T21:05:00.000Z Deano’s Pasta recalls 20 lbs of ravioli over undeclared lobster allergen https://pharmadog.xyz/news/451027 pharmadog en 2026-09-24T20:45:00.000Z Galil Importing Corp recalls Lior ground cinnamon over elevated lead levels https://pharmadog.xyz/news/450671 pharmadog en 2026-09-24T20:21:32.000Z FDA nominee Heidi Overton avoids taking positions in Senate hearing on vaccines, China and abortion https://pharmadog.xyz/news/450503 pharmadog en 2026-09-24T19:30:38.000Z STAT's The Readout LOUD podcast goes international with a Shanghai dispatch on China's biotech surge https://pharmadog.xyz/news/450315 pharmadog en 2026-09-24T18:53:03.000Z FDA warns Houston compounding pharmacy of unsanitary GLP-1 production risking contamination https://pharmadog.xyz/news/450075 pharmadog en 2026-09-24T17:08:50.000Z Elevar Therapeutics receives FDA approval for Lyrfigtu as second-line treatment for bile duct cancer https://pharmadog.xyz/news/449951 pharmadog en 2026-09-24T16:38:12.000Z Senate Finance Committee Advances Chris Klomp’s HHS Deputy Nomination https://pharmadog.xyz/news/449803 pharmadog en 2026-09-24T15:34:00.000Z Merck's remigromig meets visual acuity goal in diabetic macular edema trial, safety signals noted https://pharmadog.xyz/news/449739 pharmadog en 2026-09-24T15:30:48.000Z Roche signs discovery partnerships with Atavistik Bio and Earendil Labs https://pharmadog.xyz/news/449740 pharmadog en 2026-09-24T15:05:48.000Z Sarepta Therapeutics agrees to pay $39 million to settle gene therapy dispute with Regenxbio https://pharmadog.xyz/news/453723 pharmadog en 2026-09-24T14:59:00.000Z Travere appoints former Amicus CEO Bradley Campbell as new chief executive https://pharmadog.xyz/news/449615 pharmadog en 2026-09-24T14:57:54.000Z Indonesian court strikes down patent evergreening amendment, signaling pushback on drug pricing tactics https://pharmadog.xyz/news/449571 pharmadog en 2026-09-24T14:50:01.000Z Acadia’s Alzheimer’s psychosis drug misses Phase 2 goals, but moves to revised Phase 3 https://pharmadog.xyz/news/449573 pharmadog en 2026-09-24T14:26:11.000Z AI doomsday warnings may curb health-tech innovation, Epic cautions https://pharmadog.xyz/news/449595 pharmadog en 2026-09-24T14:25:32.000Z Acadia’s Alzheimer’s psychosis drug misses primary goal but advances on secondary data https://pharmadog.xyz/news/449635 pharmadog en 2026-09-24T14:14:00.000Z Eli Lilly inks $3.35 B China partnership as Immunovant halts lupus drug trial https://pharmadog.xyz/news/450434 pharmadog en 2026-09-24T14:10:00.000Z FDA nominee Heidi Overton affirms safety of vaccines and mifepristone in Senate hearing https://pharmadog.xyz/news/449447 pharmadog en 2026-09-24T13:52:10.000Z Kyverna reports durable responses in early cell therapy trial for autoimmune disease https://pharmadog.xyz/news/449427 pharmadog en 2026-09-24T13:51:12.000Z Merck’s eye-drug matches Lucentis in vision improvement but raises safety concerns https://pharmadog.xyz/news/449428 pharmadog en 2026-09-24T13:27:54.000Z Kyverna reports one-year mobility gains and safety for CAR-T miv-cel in stiff-person syndrome, bolstering FDA filing plans https://pharmadog.xyz/news/449448 pharmadog en 2026-09-24T13:21:50.000Z FDA nominee Heidi Overton pledges faster, more efficient regulation to keep pace with China https://pharmadog.xyz/news/449449 pharmadog en 2026-09-24T13:21:14.000Z Radiology startups say owning clinics speeds AI tool development as insurers resist new RPM rules https://pharmadog.xyz/news/449429 pharmadog en 2026-09-24T13:20:58.000Z FDA approves Eli Lilly’s weekly insulin Onswik for U.S. patients, expanding competition with Novo https://pharmadog.xyz/news/449430 pharmadog en 2026-09-24T12:59:32.000Z Basecamp Research secures $140 million Series C to accelerate AI-designed drug pipeline https://pharmadog.xyz/news/449259 pharmadog en 2026-09-24T12:43:58.000Z Roche signs up to $2 billion partnership with Atavistik to develop cardiometabolic drugs https://pharmadog.xyz/news/449127 pharmadog en 2026-09-24T12:14:05.000Z Merck's $1.3B EyeBio investment yields first ophthalmology success https://pharmadog.xyz/news/449151 pharmadog en 2026-09-24T12:12:54.000Z Eli Lilly earmarks up to $3.25 billion for partnership with InnoCare Pharma https://pharmadog.xyz/news/449003 pharmadog en 2026-09-24T11:52:28.000Z Measles deaths rise as U.S. sees worst outbreak since 1991, CDC reports four fatalities in Pennsylvania https://pharmadog.xyz/news/448835 pharmadog en 2026-09-24T10:30:00.000Z Gilead pushes further into immunology, touts inflammation drug pipeline https://pharmadog.xyz/news/448815 pharmadog en 2026-09-24T10:18:51.000Z Radioligand therapy gains momentum as experts discuss expanding patient impact https://pharmadog.xyz/news/449714 pharmadog en 2026-09-24T10:03:00.000Z Henlius Biotech signs $440 million deal with Amberstone to develop T-cell engagers https://pharmadog.xyz/news/448791 pharmadog en 2026-09-24T10:02:50.000Z Kyverna reports positive one-year CAR-T results for rare stiff person syndrome, supporting FDA filing https://pharmadog.xyz/news/448623 pharmadog en 2026-09-24T09:59:27.000Z Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billion https://pharmadog.xyz/news/449715 pharmadog en 2026-09-24T09:46:00.000Z Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing https://pharmadog.xyz/news/448502 pharmadog en 2026-09-24T08:30:00.000Z Trump administration claims all states will join Medicaid drug pricing program, but several states remain undecided https://pharmadog.xyz/news/448501 pharmadog en 2026-09-24T08:30:00.000Z Congress mulls linking Medicare doctor pay to medical inflation under Patients First Act https://pharmadog.xyz/news/448500 pharmadog en 2026-09-24T08:30:00.000Z Radiology practices increasingly develop and market in-house AI, branding themselves as AI-native https://pharmadog.xyz/news/448503 pharmadog en 2026-09-24T08:30:00.000Z Heidi Overton, Trump’s FDA nominee, to appear before Senate committee for confirmation hearing https://pharmadog.xyz/news/448504 pharmadog en 2026-09-24T08:30:00.000Z Physician who survived measles warns of rising U.S. cases and deaths https://pharmadog.xyz/news/448499 pharmadog en 2026-09-24T08:30:00.000Z Heidi Overton, a New Mexico-born physician, nominated as FDA commissioner https://pharmadog.xyz/news/448505 pharmadog en 2026-09-24T08:30:00.000Z Novartis and Novo Nordisk trials lower biomarkers but fail to cut heart events, prompting preventive cardiology rethink https://pharmadog.xyz/news/449211 pharmadog en 2026-09-24T08:15:00.000Z Merck sees pivotal victory for $3B eye disease prospect https://pharmadog.xyz/news/449210 pharmadog en 2026-09-24T08:10:00.000Z Roche signs $2 billion deal with Atavistik to discover allosteric cardiovascular-renal-metabolic drugs https://pharmadog.xyz/news/449213 pharmadog en 2026-09-24T08:05:00.000Z Adagio Medical begins strategic review and cuts over half its workforce amid Nasdaq delisting risk https://pharmadog.xyz/news/447699 pharmadog en 2026-09-24T04:01:00.000Z AI-driven interviews risk alienating biotech and pharma job seekers, experts warn https://pharmadog.xyz/news/450394 pharmadog en 2026-09-24T04:00:00.000Z Abiomed issues recall of Automated Impella Controllers over purge cassette detection issue https://pharmadog.xyz/news/447700 pharmadog en 2026-09-24T04:00:00.000Z Series B funded biotechs expand hiring, Tenpoint Therapeutics raises $85M for eye-health pipeline https://pharmadog.xyz/news/448262 pharmadog en 2026-09-24T02:39:00.000Z Eli Lilly commits $100M upfront in new five-target partnership with China's InnoCare https://pharmadog.xyz/news/449378 pharmadog en 2026-09-24T02:00:00.000Z Grail's Galleri blood test receives positive FDA advisory panel vote, moving closer to approval https://pharmadog.xyz/news/451146 pharmadog en 2026-09-24T00:00:00.000Z Senate grills Trump’s FDA nominee Heidi Overton on agency priorities https://pharmadog.xyz/news/451145 pharmadog en 2026-09-24T00:00:00.000Z FDA signals need for GCP compliance to accept foreign clinical trial data for regulatory review https://pharmadog.xyz/news/451147 pharmadog en 2026-09-24T00:00:00.000Z EMA leaders say single pivotal trial should not be default, decision must match evidence needed https://pharmadog.xyz/news/451757 pharmadog en 2026-09-24T00:00:00.000Z Senators Question FDA Nominee Overton as Agency Issues New Rule to Cut Animal Testing https://pharmadog.xyz/news/451148 pharmadog en 2026-09-24T00:00:00.000Z Senators question FDA nominee as agency issues rule to cut animal testing https://pharmadog.xyz/news/446771 pharmadog en 2026-09-23T23:26:01.000Z White House plan to tighten control over NIH grants stalls after bipartisan opposition